VYRSA-N1 SI FUSION SYSTEM

Additional Manufacturer Narrative

VYRSA SUBMITS THIS REPORT IN COMPLIANCE WITH FDA'S MEDICAL DEVICE REPORTING REGULATIONS UNDER 21 CFR PART 803. VYRSA HAS COMPLIED WITH REGULATORY INVESTIGATION REQUIREMENTS AND IS SUBMITTING ALL INFORMATION THAT IS REASONABLY KNOWN TO US AT THIS TIME. HOWEVER, WE MAY NOT HAVE BEEN ABLE TO CONFIRM THIS INFORMATION OR COMPLETE THE INVESTIGATION WITHIN THE TIMEFRAME FOR FILING THIS REPORT. WE MAY HAVE GIVEN NO RESPONSE OR AN INCOMPLETE RESPONSE TO CERTAIN QUESTIONS BECAUSE WE DO NOT CURRENTLY HAVE INFORMATION AVAILABLE TO PROVIDE A COMPLETE RESPONSE. IF WE LATER OBTAIN ANY REQUIRED INFORMATION THAT WAS NOT AVAILABLE AT THE TIME OF THIS INITIAL REPORT, WE WILL SUBMIT A SUPPLEMENTAL REPORT. THIS REPORT IS NOT AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT WAS DEFECTIVE, THAT IT MALFUNCTIONED, OR THAT IT CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THIS REPORT. WE MAY CONCLUDE THAT THE DEVICE HAD NO DEFECT, DID NOT MALFUNCTION, OR DID NOT CAUSE OR CONTRIBUTE TO A REPORTABLE EVENT. SOME OF THE ITEMS ON THIS FORM INCLUDE FORCED-CHOICE TERMS USED BY THE FDA FOR REPORTING PURPOSES THAT DO NOT NECESSARILY REFLECT VYRSA'S CONCLUSIONS ABOUT THE CAUSES OR NATURE OF THE EVENT. THIS STATEMENT SHOULD BE INCLUDED WITH ANY FREEDOM OF INFORMATION ACT RESPONSE.

Description of Event or Problem

A VYRSA N1 IMPLANT WAS PLACED IN THE SACRUM RATHER THAN THE SI JOINT SPACE. AN EXPLANT PROCEDURE TOOK PLACE ON (B)(6) 2024, TO REMOVE THE IMPLANT FROM THE SACRUM. THE PHYSICIAN HAD TO REMOVE SOME BONE AROUND THE IMPLANT DUE TO BONE GROWTH. THE SURGERY WAS COMPLETED BY ADDING TWO FIXATION SCREWS IN THE AREA. THERE HAVE BEEN NO REPORTS OF FURTHER COMPLICATIONS REGARDING THIS EVENT.